These findings provide additional insight in to the neurobiology of pediatric bipolar disorder. In the November issue of the journal Bipolar Disorders The analysis is published. Dickstein, M.D., director of the pediatric mood, imaging and neurodevelopment plan at Bradley Hospital. The analysis included 23 children with bipolar disorder and 22 typically developing children without psychiatric disorders between the age range of 7 and 17. These were then asked whether they recalled seeing the real face during the earlier test.The data was presented as an oral display by Professor Gil Mor MD PhD of Yale Medical School to the 62nd Annual Scientific Interacting with of the Society of Reproductive Investigation in SAN FRANCISCO BAY AREA, CA. In both in vitro and in animal research, Cantrixil, has proved impressive at killing human ovarian stem cells, cells that usually are highly resistant to regular of care cytotoxic drugs and which generally are thought to be responsible for diseases recurrence following preliminary therapy. Researchers have been keen to understand how the active ingredient in Cantrixil, TRXE-002, is able to accomplish that effect where other medicines have failed. The data shows that Cantrixil specifically activates the JNK-Jun pathway leading to mitochondrial damage and the induction of genes connected with cell death .